← Leaderboards
Ishwarlal Jialal
University Of Texas Sw Med Ctr/Dallas
$7,903,141
Attributed
$7,903,141
Total exposure
12
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $598.9K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$7,903,141 · 12
By mechanism
M01$3,298,266 · 7
R01$3,248,729 · 2
K24$1,303,616 · 1
P51$52,530 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Craig R. Malloy$13,817,010
- Heinrich Taegtmeyer$9,963,603
- Eunsook Jin$1,517,775
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchTocopherolsHuman SubjectLow Density LipoproteinAtherosclerosisInflammationHuman Therapy EvaluationNutrition Related TagMonocyteOxidationOxidative StressAlternative MedicineAntioxidantsCell Adhesion MoleculesDietary SupplementsAntihypercholesterolemic AgentBlood Lipoprotein MetabolismVitamin TherapyLeukocyte Activation /TransformationProtein Kinase CDiabetes MellitusDisease /Disorder Proneness /RiskRacial /Ethnic DifferenceLipid Peroxides
Grant awards (42)
CRP, Diabetes, Atherothrombosis$451,953
R01 · FY2010 · HL · contact PI
CRP, Diabetes, Atherothrombosis$456,130
R01 · FY2009 · HL · contact PI
Clinical Studies in Nutrition and Metabolism$142,733
K24 · FY2009 · AT · contact PI
Clinical Studies in Nutrition and Metabolism$142,733
K24 · FY2008 · AT · contact PI
C-Reactive Protein And Atherosclerosis$337,285
R01 · FY2007 · HL · contact PI
Clinical Studies in Nutrition and Metabolism$142,733
K24 · FY2007 · AT · contact PI
C-Reactive Protein And Atherosclerosis$362,526
R01 · FY2006 · HL · contact PI
Clinical Studies in Nutrition and Metabolism$142,733
K24 · FY2006 · AT · contact PI
DOES C-REACTIVE PROTEIN ACCENTUATE THE ENDOTHELIAL DYSFUNCTION INDUCED BY CMV?$24,804
P51 · FY2006 · RR · contact PI
C-Reactive Protein And Atherosclerosis$355,718
R01 · FY2005 · HL
Clinical Studies in Nutrition and Metabolism$142,733
K24 · FY2005 · AT
DOES C-REACTIVE PROTEIN ACCENTUATE THE ENDOTHELIAL DYSFUNCTION INDUCED BY CMV?$27,726
P51 · FY2005 · RR
C-Reactive Protein And Atherosclerosis$367,843
R01 · FY2004 · HL
High Dose Alpha Tocopherol and Carotid Atherosclerosis$151,478
R01 · FY2004 · AT
CLINICAL STUDIES IN NUTRITION AND METABOLISM$117,800
K24 · FY2004 · AT
High Dose Alpha Tocopherol and Carotid Atherosclerosis$37,125
R01 · FY2004 · AT
SIMVASTATIN ON MONOCYTE PRO-INFLAMMATORY CYTOKINES &HSCRPIN PATIENTS WITH THE M$9,450
M01 · FY2004 · RR
MONOCYTE FUNCTION AND INFLAMMATION IN TYPE I DIABETES AND ITS MODULATION$5,400
M01 · FY2004 · RR
High Dose Alpha Tocopherol and Carotid Atherosclerosis$175,096
R01 · FY2003 · AT
CLINICAL STUDIES IN NUTRITION AND METABOLISM$117,800
K24 · FY2003 · AT
EFFECT OF ALPHA TOCOPHEROL AND ALPHA LIPOATE ON LDL OXIDATION$321,374
M01 · FY2002 · RR
PHYSIOLOGIC ANTIOXIDANT AGENTS AND OXIDATIVE MODIFICATION OF LDL$321,374
M01 · FY2002 · RR
ALPHA TOCOPHEROL EFFECT ON MONOCYTES IN RELATION TO ATHEROGENESIS$321,374
M01 · FY2002 · RR
EFFECT OF VITAMIN E ON LDL MODIFICATION AND MONOCYTE FUNCTION$321,374
M01 · FY2002 · RR
VITAMIN E SUPPLEMENTATION AND LDL OXIDATION$321,374
M01 · FY2002 · RR
CLINICAL STUDIES IN NUTRITION AND METABOLISM$117,800
K24 · FY2002 · AT
ALPHA TOCOPHEROL EFFECT ON MONOCYTES IN RELATION TO ATHEROGENESIS$321,374
M01 · FY2001 · RR
EFFECT OF VITAMIN E ON LDL MODIFICATION AND MONOCYTE FUNCTION$321,374
M01 · FY2001 · RR
PHYSIOLOGIC ANTIOXIDANT AGENTS AND OXIDATIVE MODIFICATION OF LDL$321,374
M01 · FY2001 · RR
EFFECT OF ALPHA TOCOPHEROL AND ALPHA LIPOATE ON LDL OXIDATION$321,374
M01 · FY2001 · RR
VITAMIN E SUPPLEMENTATION AND LDL OXIDATION$321,374
M01 · FY2001 · RR
EFFECT OF HIGH DOSE VITAMIN E ON CAROTID ATHERSCLEROSIS$227,140
R01 · FY2001 · AT
EFFECT OF HIGH DOSE VITAMIN E ON CAROTID ATHERSCLEROSIS$144,500
R01 · FY2001 · AT
CLINICAL STUDIES IN NUTRITION AND METABOLISM$117,800
K24 · FY2001 · AT
CLINICAL STUDIES IN NUTRITION AND METABOLISM$951
K24 · FY2001 · AT
EFFECT OF HIGH DOSE VITAMIN E ON CAROTID ATHERSCLEROSIS$181,935
R01 · FY2000 · AT
CLINICAL STUDIES IN NUTRITION AND METABOLISM$117,800
K24 · FY2000 · AT
ALPHA TOCOPHEROL EFFECT ON MONOCYTES IN RELATION TO ATHEROGENESIS$34,838
M01 · FY2000 · RR
PHYSIOLOGIC ANTIOXIDANT AGENTS AND OXIDATIVE MODIFICATION OF LDL$34,838
M01 · FY2000 · RR
EFFECT OF ALPHA TOCOPHEROL AND ALPHA LIPOATE ON LDL OXIDATION$0
M01 · FY2000 · RR
VITAMIN E SUPPLEMENTATION AND LDL OXIDATION$0
M01 · FY2000 · RR
EFFECT OF VITAMIN E ON LDL MODIFICATION &MONOCYTE FUNCTION$0
M01 · FY2000 · RR